Aleksander Krag
Aleksander Krag
Professor of Hepatology, Odense Universityhospital
Verified email at rsyd.dk
Title
Cited by
Cited by
Year
Expanding consensus in portal hypertension Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension
BVIF de Franchis, Roberto
Journal of Hepatology 63 (3), 743-52, 2015
17022015
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
European Association for the Study of the Liver
Journal of hepatology 69 (2), 406-460, 2018
5002018
Spontaneous bacterial peritonitis: recent guidelines and beyond
R Wiest, A Krag, A Gerbes
Gut 61 (2), 297-310, 2012
3692012
Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome
LL Gluud, K Christensen, E Christensen, A Krag
Hepatology 51 (2), 576-584, 2010
3342010
Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites
A Krag, F Bendtsen, JH Henriksen, S Møller
Gut 59 (01), 105-110, 2010
3092010
Terlipressin for hepatorenal syndrome
LL Gluud, K Christensen, E Christensen, A Krag
Cochrane Database of Systematic Reviews, 2012
2222012
Treatment of patients with cirrhosis
PS Ge, BA Runyon
New England Journal of Medicine 375 (8), 767-777, 2016
2062016
Assessment of biopsy‐proven liver fibrosis by two‐dimensional shear wave elastography: An individual patient data‐based meta‐analysis
E Herrmann, V de Lédinghen, C Cassinotto, WCW Chu, VYF Leung, ...
Hepatology 67 (1), 260-272, 2018
1712018
The window hypothesis: haemodynamic and non-haemodynamic effects of β-blockers improve survival of patients with cirrhosis during a window in the disease
A Krag, R Wiest, A Albillos, LL Gluud
Gut 61 (7), 967-969, 2012
1662012
Banding ligation versus beta‐blockers for primary prevention in oesophageal varices in adults
LL Gluud, A Krag
Cochrane Database of Systematic Reviews, 2012
1612012
Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome
A Krag, S Møller, JH Henriksen, NH Holstein‐Rathlou, FS Larsen, ...
Hepatology 46 (6), 1863-1871, 2007
1592007
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ...
The Lancet 394 (10215), 2184-2196, 2019
1422019
Novel insights into the function and dynamics of extracellular matrix in liver fibrosis
MA Karsdal, T Manon-Jensen, F Genovese, JH Kristensen, MJ Nielsen, ...
American Journal of Physiology-Gastrointestinal and Liver Physiology 308 (10 …, 2015
1422015
Systematic review with meta‐analysis: the effects of rifaximin in hepatic encephalopathy
N Kimer, A Krag, S Møller, F Bendtsen, LL Gluud
Alimentary pharmacology & therapeutics 40 (2), 123-132, 2014
1352014
Transient and 2-dimensional shear-wave elastography provide comparable assessment of alcoholic liver fibrosis and cirrhosis
M Thiele, S Detlefsen, LS Møller, BS Madsen, JF Hansen, AD Fialla, ...
Gastroenterology 150 (1), 123-133, 2016
1292016
Treatment of acute variceal bleeding
F Bendtsen, A Krag, S Møller
Digestive and liver disease 40 (5), 328-336, 2008
1012008
Nonselective β‐blockers do not affect mortality in cirrhosis patients with ascites: Post Hoc analysis of three randomized controlled trials with 1198 patients
L Bossen, A Krag, H Vilstrup, H Watson, P Jepsen
Hepatology 63 (6), 1968-1976, 2016
882016
Meta‐analysis: banding ligation and medical interventions for the prevention of rebleeding from oesophageal varices
M Thiele, A Krag, U Rohde, LL Gluud
Alimentary pharmacology & therapeutics 35 (10), 1155-1165, 2012
852012
Nutritional therapy in cirrhosis or alcoholic hepatitis: a systematic review and meta‐analysis
AD Fialla, M Israelsen, O Hamberg, A Krag, LL Gluud
Liver International 35 (9), 2072-2078, 2015
802015
Meta‐analysis: the safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia
E Dahl, LL Gluud, N Kimer, A Krag
Alimentary pharmacology & therapeutics 36 (7), 619-626, 2012
802012
The system can't perform the operation now. Try again later.
Articles 1–20